Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for QuidelOrtho Corporation (QDEL : NSDQ)

• Company Description    QuidelOrtho is a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems. The company's brand names include Sofia(R), Solana(R), Lyra(R), Triage(R) and QuickVue(R). Its comprehensive product portfolio includes tests for a range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. QuidelOrtho, formerly known as Quidel Corporation, is based in SAN DIEGO. Number of Employees: 6,500

• Price / Volume Information    Yesterday's Closing Price: $11.39 Daily Weekly Monthly 20 Day Moving Average: 2,626,398 shares Shares Outstanding: 68.19 (millions) Market Capitalization: $776.70 (millions) Beta: 0.75 52 Week High: $35.58 52 Week Low: $9.92 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -10.21% -15.72% 12 Week -51.76% -55.87% Year To Date -60.12% -63.60%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 9975 SUMMERS RIDGE ROAD - SAN DIEGO,CA 92121 USA ph: 858-552-1100 fax: 858-453-4338 ir@quidelortho.com http://www.quidelortho.com

• General Corporate Information    Officers Brian J. Blaser - President and Chief Executive Officer Kenneth F. Buechler - Chairman of the Board Joseph M. Busky - Chief Financial Officer John R. Chiminski - Director Evelyn S. Dilsaver - Director Peer Information QuidelOrtho Corporation (BJCT) QuidelOrtho Corporation (CADMQ) QuidelOrtho Corporation (APNO) QuidelOrtho Corporation (UPDC) QuidelOrtho Corporation (IMTIQ) QuidelOrtho Corporation (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 219798105 SIC: 2835 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/04/26 Share - Related Items Shares Outstanding: 68.19 Most Recent Split Date: (:1) Beta: 0.75 Market Capitalization: $776.70 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.04 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $1.83 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/04/26

• Fundamental Ratios P/E Current FY Estimate: 6.22 Trailing 12 Months: 8.50 PEG Ratio: - Price Ratios Price/Book: 0.42 Price/Cash Flow: 0.60 Price / Sales: 0.29 EPS Growth vs. Year Ago Period: -105.41% vs. Previous Quarter: -108.70% Sales Growth vs. Year Ago Period: -10.54% vs. Previous Quarter: -14.34% ROE 03/31/26 - 4.25 12/31/25 - 5.91 09/30/25 - 5.75 ROA 03/31/26 - 1.56 12/31/25 - 2.37 09/30/25 - 2.49 Current Ratio 03/31/26 - 1.43 12/31/25 - 1.50 09/30/25 - 1.78 Quick Ratio 03/31/26 - 0.80 12/31/25 - 0.90 09/30/25 - 0.98 Operating Margin 03/31/26 - 3.44 12/31/25 - 5.27 09/30/25 - 5.72 Net Margin 03/31/26 - -45.57 12/31/25 - -41.46 09/30/25 - -42.53 Pre-Tax Margin 03/31/26 - -44.35 12/31/25 - -40.57 09/30/25 - -41.86 Book Value 03/31/26 - 27.15 12/31/25 - 28.27 09/30/25 - 29.98 Inventory Turnover 03/31/26 - 2.46 12/31/25 - 2.50 09/30/25 - 2.51 Debt-to-Equity 03/31/26 - 1.33 12/31/25 - 1.29 09/30/25 - 1.23 Debt-to-Capital 03/31/26 - 57.06 12/31/25 - 56.28 09/30/25 - 55.08

Powered by Zacks Investment Research ©